In recent times, there has been a large increase in the number of protein structures deposited in the Protein Data Bank. Structural genomics initiatives have contributed to this expansion through their focus on high-throughput structural determination. This has fuelled advances in many of the techniques in the pipeline from gene to protein to crystal to structure. These include ligation-independent cloning methods, parallel purification systems, robotic crystallization devices and automated methods of crystal identification, data collection and, in some cases, structure solution. Some of these advances are described and discussed briefly with an emphasis on activities in the York Structural Biology Laboratory through its participation in the Structural Proteomics in Europe consortium.
Introduction
Insights arising from protein crystallography have contributed significantly to our understanding of gene expression and its regulation. On the one hand, crystal structures reveal the molecular arrangements in macromolecular complexes that regulate transcription exemplified by the tryptophan attenuator protein-RNA complex [1] (Figure 1, left) , and, on the other, they reveal details of the mechanism of action of transcriptional machines such as bacterial RNA polymerase ( Figure 1 , right) [2] and the mode of action of antibiotics [3] . The pipeline [4] , from the nucleotide sequence of a gene of interest to the three-dimensional co-ordinate set that is the structure of the encoded protein, is an extended one with many potential bottlenecks. The steps notionally include bioinformatics analysis of genomic sequences to identify targets, gene amplification by PCR and capture in an expression vector, soluble protein overexpression from cell cultures, protein purification and crystallization, crystal handling and selection of the most promising crystals for X-ray analysis, data collection and processing and structural determination and model refinement. Structural proteomics projects of various types have provided a strong stimulus for adapting the steps in the pipeline to higher throughput [4] . Thus the last few years have witnessed a transformation in the approach to structural determination characterized by increasing breadth in target lists and increasing use of robotics devices and a concomitant reduction in the sample sizes required. In the present article, we summarize the developments in the gene to diffracting crystal segment of the pipeline, in an account which is strongly biased towards those methods implemented in our own laboratory and by our participation in the SPINE (Structural Proteomics in Europe) consortium (http://www.spineurope.org).
Molecular biology
To express protein targets in Escherichia coli, a LIC (ligationindependent cloning) [5] expression vector (pET-YSBLIC) has been constructed. The LIC site was introduced between the NcoI and NdeI restriction endonuclease cleavage sites of a pET-28a (Novagen) derivative (Figure 2a ). This region contains sequence encoding a His 6 protein purification tag and a human rhinovirus 3C protease cleavage site [6] . A pair of mutagenic amplification primers ( Figure 2b ) and wholeplasmid PCR were used to generate the LIC site which contains recognition sequences for two unique restriction endonucleases AscI (5 -GGCGCGCC-3 ) and BseRI (5 -GAGGAG-3 ). The primers also altered the His 3 , His 4 and His 5 codons of the His 6 tag from CAT to CAC (Figure 2c ). The effect of these mutations is to eliminate thymine bases from the LIC region.
BseRI is a type IIS restriction endonuclease with the recognition sequence GAGGAG. Treatment of pET-YSBLIC with BseRI leads to staggered cleavage 8 and 10 bp upstream of the recognition sequence on either strand producing a linearized molecule with 3 overhangs (Figure 3) . The reaction products are treated with bacteriophage T4 DNA polymerase in the presence of dTTP. This enzyme possesses a 3 -5 exonuclease activity which sequentially excises nucleotides from the 3 -ends of the DNA (Figure 3 ). The extent of this excision is determined by the sequence which is locally depleted of thymine bases. When the enzyme encounters an A base on the complementary template strand, the polymerase activity becomes dominant, and excised T bases are re-incorporated using the dTTP substrate in the reaction mixture [7] . The resulting plasmid product is therefore a linear duplex DNA with 5 -single-stranded overhangs of 13 bases on the antisense strand and 14 bases on the sense strand ( Figure 3 ). Large batches of the pET-YSBLIC can be treated in this way to produce sufficient material for cloning several hundred PCR products. The sequences encoding each of the target genes of interest are amplified using a pair of gene-specific primers with sequences complementary to the 5 -and 3 -ends of the coding sequences. Each 5 -primer contains a common 5 noncomplementary LIC extension. As a result, following gene amplification from chromosomal template DNA, all of the PCR fragments are flanked by a common pair of sequences. As shown in Figure 3 , treatment of the PCR products with T4 DNA polymerase in the presence of dATP produces fragments with 5 -single-stranded overhangs of 13 and 14 bp in the antisense and sense strands respectively. These overhangs are perfectly complementary to those generated in the vector.
Annealing of the treated vector and PCR fragments for 10 min at room temperature produces a circular duplex species with staggered nicks on each strand. This duplex species is sufficiently stable for it to be introduced directly into competent E. coli cells of a cloning strain such as NovaBlue (Novagen) where the nicks are repaired, effectively completing the cloning reaction.
The recombinant plasmids encode the protein of interest with an N-terminal MSSGHHHHHH tag fused at the Nterminus, the only constraint being that an ATG codon for a methionine residue follows the tag. These procedures for performing the PCR and cloning reactions are easily adapted to high-throughput methodologies, so that the combination of a liquid-handling robot and a colony picker, for a single round of cloning, can deliver cloning efficiencies Upper panels: the target ORF (open reading frame) is amplified by PCR using specific oligonucleotides with LIC-additions (underlined) at their 5 -termini. The PCR product is purified and LIC-specific 5 -single-stranded overhangs are generated by incubating with T4 DNA polymerase (T4 pol) in the presence of dATP. Lower panels: BseRI is used to cleave and linearize pET-YSBLIC DNA. 5 -Single-stranded overhangs are generated in the linearized vector by incubation with T4 DNA polymerase and dTTP. The overhangs are complementary to those in the PCR products. The reaction products are allowed to anneal and used directly to transform competent cells of a suitable E. coli strain.
of > 80% easily, rapidly and in a 96-well format. The same robotic platform facilitates the subsequent parallel recovery of recombinant plasmids before DNA sequencing and protein expression. Where there are concerns about the effects of the His 6 tag on protein function and/or crystallizability, the gene of interest can be recloned into a similar LIC vector (pET-YSBLIC3C) engineered so that sequence encoding the human rhinovirus 3C protease cleavage site is retained.
Protein expression and purification
In pET-YSBLIC, the cloned gene is transcribed from the T7 RNA polymerase promoter under the control of the lac operator. Recombinant plasmids, using the robotic platform, are introduced into an expression strain such as E. coli BL21(DE3), a λDE3 lysogen-harbouring bacteriophage gene 1 (encoding T7 RNA polymerase) under lac promoter control. As a result, production of both T7 RNA polymerase and the target protein are regulated by the lac repressor, also expressed from pET-YSBLIC. This allows induction of recombinant gene expression by addition of IPTG (isopropyl β-D-thiogalactoside). For parallel cultures, however, autoinduction on a defined glucose/lactose medium is favoured as it obviates the need for cell cultures to be synchronized [8] . Instead, cells are grown overnight, with induction taking place upon exhaustion of the glucose at high cell densities and the concomitant switch to lactose metabolism. An additional advantage of auto-induction is that the higher cell densities achieved provide more biomass per unit volume of culture.
The proteins expressed from pET-YSBLIC harbouring a His 6 tag are purified by HisTrap TM HP (Ni 2+ -Sepharose) (GE Healthcare) affinity and gel filtration. These steps can be carried out in parallel for up to 16 target protein extracts using anÄKTAxpress (GE Healthcare) system.
Protein crystallization
The tried and tested method of protein crystallization is vapour diffusion from either hanging or sitting drops exploring as wide a range of crystallization solutions as is practicable. The laborious preparation of buffer and precipitants can be avoided through the use of commercially available or locally curated crystallization screens. The crystallization experiments themselves can be set up using a system of liquid-handling robots [9] . At York, a Tecan robot is used to prepare the master block of crystallization solutions. Samples of 100 μl or so of these solutions are dispensed into crystallization trays using a Hydra robot to form the reservoir solutions. Finally, a MOSQUITO (TTP-LabTech) robot dispenses and mixes the protein solution and the reservoir solution to form the crystallization drop. An additional advantage of the robotics systems is scale-down with protein drop sizes reduced to 150 nl, enabling many more conditions to be screened per mg of protein sample.
In a recent development, a new microplate has been designed and tested in which the size of the reservoir solution is reduced to 1.5 μl. This is especially desirable where the precipitant solutions are precious [10] , for example if they contain expensive or scarce polymers, such as those being developed for the crystallization of membrane proteins. Furthermore, because of the smaller volumes, the new plates reduce the time required for crystal nucleation and growth, in some cases shortening the high-throughput crystallization screening process to a few hours.
The combined effect of these developments is that it is possible very quickly to set up a large number of crystallization experiments. To monitor the progress of so many experiments, a number of laboratories have acquired imaging systems for examining the drops at specified intervals. In this way, the experimenter obtains a detailed and permanent record of the crystallization process. To facilitate the analysis of this vast array of data, crystal recognition software has been developed to alert the user to those crystallization drops among the enormous array set up that contain the most promising candidates for crystals [9, 11] .
Crystal analysis and data collection
Once crystals appear, the next step is to establish the quality and extent of their diffraction and to choose the most suitable crystals for data collection. To extend their lifetime in the Xray beam, crystals are normally cryo-cooled in liquid nitrogen before mounting on the X-ray apparatus. It is more often than not necessary to test a number of different crystals and cryoprotectants. In addition to crystal transfers between solutions, this involves mounting of the crystals on the Xray apparatus and centring of the crystal in the X-ray beam. This process has been streamlined with the development of standard crystal sample holders and vials which can be manipulated by a robotic sample handler capable of mounting a series of crystals on the diffractometer without the need for user intervention [12] .
In a typical project, protein crystals are tested on a home laboratory X-ray source, with the best crystals being accompanied to a synchrotron radiation source for the collection of high-quality data to the highest possible resolution. With standardized sample holders compatible with synchrotron beamline sample changers, efficient use of the synchrotron radiation time can be made. Most recently, it has become possible to send samples unaccompanied to the beamline and to manage data collection from the home laboratory through the use of web-cameras.
Overcoming the solubility bottleneck
The primary bottleneck in the pipeline to high-throughput structural determination occurs at the stage of soluble protein expression. This can be because the recombinant protein fails to be expressed or, once expressed, is unstable. Alternatively, when the protein is produced at high levels, it may not be soluble.
To overcome this problem for high-value protein targets, directed evolution approaches are being developed with the goal of identifying soluble protein fragments. One such technique is ESPRIT (expression of soluble protein domains by random incremental truncation) [13] . This technique exploits a biotin acceptor peptide fused to the terminus of the recombinant polypeptide. This peptide will become biotinylated in vivo, only if the polypeptide to which it is attached is soluble. By screening many thousands of colonies printed as an array, it was possible to identify a soluble Cterminal fragment of the influenza virus DNA polymerase PB2 subunit that plays a role in nuclear import. This hitherto intractable target allowed determination of structures by both NMR and crystallographic methods [13] .
